Servatus is focused on the development of effective treatments for chronic and inflammatory diseases - especially auto-immune diseases.
Servatus Biopharmaceuticals's investors include Melbourne Angels, Brisbane Medtech Accelerator.
Servatus Biopharmaceuticals is headquartered in Sippy Downs, Australia.
Servatus is focused on the development of effective treatments for chronic and inflammatory diseases - especially auto-immune diseases.
Servatus Biopharmaceuticals is at the Non-equity Assistance stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Servatus Biopharmaceuticals — Funding & Investors." VCBacked, July 18, 2024, https://www.vcbacked.co/company/servatus-biopharmaceuticals. Accessed September 29, 2026.
VCBacked. (2024). Servatus Biopharmaceuticals — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/servatus-biopharmaceuticals
{{cite web |title=Servatus Biopharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/servatus-biopharmaceuticals |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated